arrow
L

Lien Anh Ha

Murdoch Children's Research Institute
H指数:23
被引数:4,022

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial

分数剂量BNT162b2加强针在蒙古非mRNA基础免疫后诱导持久的免疫反应:一项随机对照试验

2026-03-270
OAAI
Pneumococcal carriage and disease in adults hospitalised with community-acquired pneumonia in Mongolia: prospective pneumonia surveillance program (2019–2022)

蒙古国社区获得性肺炎住院成人中的肺炎链球菌携带与疾病情况:前瞻性肺炎监测计划(2019–2022)

2025-11-250
OAAI
Immunogenicity and safety at twelve months of fractional and standard BNT162b2 booster doses in adults primed with ChAdOx1-S, BBIBP-CorV, or Gam-COVID-Vac in Mongolia: a randomised controlled trial

蒙古国成人中使用ChAdOx1-S、BBIBP-CorV或Gam-COVID-Vac进行基础免疫后,接受 fractional 和 standard 剂量的 BNT162b2 加强针在十二个月时的免疫原性和安全性:一项随机对照试验

Vaccine
IF3.5
2025-10-090
OAAI
Respiratory Syncytial Virus and Influenza Infections in Children in Ulaanbaatar, Mongolia, 2015-2021

2015-2021蒙古乌兰巴托儿童的呼吸道合胞病毒和流感感染

2024-05-160
OA
Differential anti-viral response to respiratory syncytial virus A in preterm and term infants
2024-04-011
OAAI
Immunogenicity, safety, and reactogenicity of a halfversus full-dose BNT162b2 (Pfizer-BioNTech) booster following a two-dose ChAdOx1 nCoV-19, BBIBP-CorV, or Gam-COVID-Vac priming schedule in Mongolia: a randomised, controlled, non-inferiority trial
2024-01-012
OAAI
TLR Responses in Preterm and Term Infant Cord Blood Mononuclear Cells
2023-04-146
OAAI
Virology and immune dynamics reveal high household transmission of ancestral SARS-CoV-2 strain

病毒学和免疫动力学揭示了祖先SARS-CoV-2株的高家庭传播

2022-07-115
OA
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis

2019年5岁以下儿童呼吸道合胞病毒引起的急性下呼吸道感染的全球、区域和国家疾病负担估计: 一项系统分析

LANCET
IF88.5
2022-05-01738
OAAI
Comparison of Seroconversion in Children and Adults With Mild COVID-19
2022-03-0960
OAAI
A case report describing the immune response of an infant with congenital heart disease and severe COVID-19
2021-11-150
OA